You are here

diabetes

U.S. Senate to Take Up Proposed $35 Insulin Cap this Spring

BioSpace

Mon, 03/28/22 - 07:54 pm

Novo Nordisk and Novartis put Victoza patent suit to bed, teeing up Sandoz copycat by 2024

Fierce Pharma

Wed, 03/23/22 - 10:38 am

Insulin price caps on the horizon as Senate leader plans vote

Pharmaforum

Wed, 03/23/22 - 10:33 am

Diabetes data put Better Therapeutics’ digital offering on track for FDA filing

MedCity News

Wed, 03/16/22 - 10:07 am

Better Therapeutics

digital therapeutics

Civica aims to launch low-cost insulin in U.S. by 2024

Yahoo/Reuters

Thu, 03/3/22 - 10:17 am

Medtronic talks diabetes group's FDA warning letter, new products, supply chain constraints

Medtech Dive

Mon, 02/21/22 - 10:40 am

Senseonics’ long-lasting continuous glucose monitor receives FDA approval

MedCity News

Tue, 02/15/22 - 10:12 am

continuous glucose monitoring

glucose monitors

Taking on Big Pharma-sized indications, tiny biotech claims early win in fat loss. Will it translate to diabetes, NASH and beyond?

Endpoints

Wed, 02/9/22 - 10:01 am

Rivus Pharmaceuticals

Pfizer accuses former employees of 'treachery' in stealing trade secrets to form Regor Therapeutics

Fierce Biotech

Thu, 02/3/22 - 10:34 am

BD’s Diabetes Spinoff Gets Name and Launch Date

Medical Devices and Diagnostics Industry

Wed, 02/2/22 - 11:06 am

Becton Dickinson

Glooko Keeps Diabetes Management Space Hot with M&A

Medical Devices and Diagnostics Industry

Mon, 01/31/22 - 11:47 pm

artificial intelligence

machine learning

Viatris yanks one batch of diabetes med Semglee because of missing label risks

Fierce Pharma

Fri, 01/21/22 - 11:00 am

Eli Lilly lines up metabolic pacts with Evotec, Abbisko as it awaits diabetes med nod from FDA

Fierce Biotech

Tue, 01/18/22 - 11:49 pm

Abbisko Therapeutics

Novo Nordisk comes out clean in $1.8B investor lawsuit alleging insulin misdirection

Fierce Pharma

Mon, 01/17/22 - 10:55 am

JPM 2022: Eli Lilly CEO mulls using Novo's double-branding trick on tirzepatide—one obesity, one diabetes

Fierce Pharma

Wed, 01/12/22 - 11:10 am

Diabetes device makers lead the smaller medtechs

EP Vantage

Tue, 01/11/22 - 11:26 am

Fulgent Genetics

Tandem Diabetes Care

FDA Decision on Senseonics' 180-Day CGM Expected in Coming Weeks

Medical Devices and Diagnostics Industry

Thu, 01/6/22 - 12:34 pm

continuous glucose monitoring

Eli Lilly enters strike mode ahead of pivotal Alzheimer's, diabetes launches, CFO says

Fierce Pharma

Mon, 12/20/21 - 11:04 am

Alzheimer's disease

Medtronic hit with FDA warning letter for diabetes devices

MedCity News

Thu, 12/16/21 - 11:20 am

Tandem Diabetes Care targets 1M customers by 2027

Medtech Dive

Tue, 12/7/21 - 11:49 pm

Tandem Diabetes Care

Pages